Literature DB >> 26845587

Paul Ehrlich (1854-1915) and His Contributions to the Foundation and Birth of Translational Medicine.

Peter Valent1, Bernd Groner, Udo Schumacher, Giulio Superti-Furga, Meinrad Busslinger, Robert Kralovics, Christoph Zielinski, Josef M Penninger, Dontscho Kerjaschki, Georg Stingl, Josef S Smolen, Rudolf Valenta, Hans Lassmann, Heinrich Kovar, Ulrich Jäger, Gabriela Kornek, Markus Müller, Fritz Sörgel.   

Abstract

Translational research and precision medicine are based on a profound knowledge of cellular and molecular mechanisms contributing to various physiologic processes and pathologic reactions in diverse organs. Whereas specific molecular interactions and mechanisms have been identified during the past 5 decades, the underlying principles were defined much earlier and originate from to the seminal observations made by outstanding researchers between 1850 and 1915. One of the most outstanding exponents of these scientists is Paul Ehrlich. His work resulted not only in the foundation and birth of modern hematology and immunology, but also led to the development of chemotherapy and specific targeted treatment concepts. In 2015, the Medical University of Vienna organized a memorial meeting, with the aim of honoring Paul Ehrlich's contributions to science, and to commemorate the 100th anniversary of his death. The authors of the current review served as faculty members and dedicate this paper to Paul Ehrlich and his remarkable contributions to medicine.
© 2016 S. Karger AG, Basel.

Mesh:

Year:  2016        PMID: 26845587      PMCID: PMC6738855          DOI: 10.1159/000443526

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  19 in total

1.  Gone with the Wind--Innate Immunity and Airway Inflammation.

Authors:  Heiko Herwald; Arne Egesten
Journal:  J Innate Immun       Date:  2016-03-01       Impact factor: 7.349

2.  The Resurrection of Phenotypic Drug Discovery.

Authors:  Wayne E Childers; Khaled M Elokely; Magid Abou-Gharbia
Journal:  ACS Med Chem Lett       Date:  2020-03-06       Impact factor: 4.345

3.  Introduction to Immunohistochemistry: From to Evolving Science to Timeless Art.

Authors:  Luis Del Valle
Journal:  Methods Mol Biol       Date:  2022

Review 4.  Molecular targeted therapy for anticancer treatment.

Authors:  Hye-Young Min; Ho-Young Lee
Journal:  Exp Mol Med       Date:  2022-10-12       Impact factor: 12.153

5.  Evolution of drug delivery systems: From 1950 to 2020 and beyond.

Authors:  Haesun Park; Andrew Otte; Kinam Park
Journal:  J Control Release       Date:  2021-12-29       Impact factor: 11.467

Review 6.  The regulatory role of eosinophils in viral, bacterial, and fungal infections.

Authors:  Pratibha Gaur; Ilan Zaffran; Tresa George; Fidan Rahimli Alekberli; Micha Ben-Zimra; Francesca Levi-Schaffer
Journal:  Clin Exp Immunol       Date:  2022-07-22       Impact factor: 5.732

7.  Pragmatic medicine in solid cancer: a translational alternative to precision medicine.

Authors:  Jan Brábek; Daniel Rosel; Michael Fernandes
Journal:  Onco Targets Ther       Date:  2016-04-05       Impact factor: 4.147

Review 8.  Two Decades of 4D-QSAR: A Dying Art or Staging a Comeback?

Authors:  Andrzej Bak
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

Review 9.  Targeted Drug Delivery - From Magic Bullet to Nanomedicine: Principles, Challenges, and Future Perspectives.

Authors:  Ashagrachew Tewabe; Atlaw Abate; Manaye Tamrie; Abyou Seyfu; Ebrahim Abdela Siraj
Journal:  J Multidiscip Healthc       Date:  2021-07-05

10.  Dual targeting of the cancer antioxidant network with 1,4-naphthoquinone fused Gold(i) N-heterocyclic carbene complexes.

Authors:  R McCall; M Miles; P Lascuna; B Burney; Z Patel; K J Sidoran; V Sittaramane; J Kocerha; D A Grossie; J L Sessler; K Arumugam; J F Arambula
Journal:  Chem Sci       Date:  2017-07-21       Impact factor: 9.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.